TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 14, 2024 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.36. Operator: Good morning, and ...
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Detailed price information for Shuttle Pharmaceuticals Holdings Inc (SHPH-Q) from The Globe and Mail including charting and trades.
Medindia6h
New Plug-and-Play Tool for Monitoring T-cell Immunotherapy Outcomes
Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...
Science Daily15h
Scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness
A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...
Science Daily17h
Drug combination prompts immune response in some resistant pancreatic cancers
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.
Miniature Lab-Grown Immune Systems Could Transform Cancer Treatment Research
The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...